• Busca persones
• Intranet

Biomarcadors en Fluids i Neurologia Translacional Marc Suárez-Calvet

Publicacions 2025 (14)

• Forcano L, Soldevila N, Boronat A, Sánchez-Benavides G, Puig-Pijoan A, Lorenzo T, Aldea-Perona A, Suarez-Calvet M, Cuenca A, Gispert JD, Gomis-González M, Minguillón C, Diaz-Pellicer P, Fauria K, Piera I, Langohr K, Dierssen M, Pizarro N, Mur-Gimeno E, Grau-Rivera O, Molinuevo JL, de la Torre R^*, PENSA working group. A multimodal lifestyle intervention complemented with epigallocatechin gallate to prevent cognitive decline in APOE- ε4 carriers with Subjective Cognitive Decline: a randomized, double-blinded clinical trial (PENSA study). JPAD-J PREV ALZHEIM 2025: (en Premsa).
  Cites:0
  Cites:0
• Cumplido-Mayoral I, Sánchez-Benavides G, Vilor N, López D, Brugulat-Serrat A, Milà M, Falcon C, Cacciaglia R, Minguillón C, Fauria K, Kollmorgen G, Quijano-Rubio C, Molinuevo JL, Grau-Rivera O, Suarez-Calvet M^*, Vilaplana V, Gispert JD^*, ADNI study. Neuroimaging-derived biological brain age and its associations with glial reactivity and synaptic dysfunction cerebrospinal fluid biomarkers. Mol Psychiatr 2025; 30(8): 3718-3728.
  Cites:0
  Cites:0
• Palmqvist S^*, Warmenhoven N, Anastasi F, Pilotto A, Janelidze S, Tideman P, Stomrud E, Mattsson-Carlgren N, Smith R, Ossenkoppele R, Tan K, Dittrich A, Skoog I, Zetterberg H, Quaresima V, Tolassi C, Höglund K, Brugnoni D, Puig-Pijoan A, Fernández A, Contador J, Padovani A, Monane M, Verghese PB, Braunstein JB, Kern S, Blennow K, Ashton NJ, Suarez-Calvet M, Hansson O^*. Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platform. Nat Med 2025; 31(6): 2036-2043.
  Cites:2
  Cites:2
• Doecke JD, Bellomo G, Vermunt L, Alcolea D, Halbgebauer S, In 't Veld S, Mattsson-Carlgren N, Veverova K, Fowler CJ, Boonkamp L, Houtkamp IM, Koel-Simmerlink M, Verberk IMW, Gaetani L, Toja A, Wojdala AL, Fortea J, Pijnenburg Y, Lemstra A, van der Flier WM, Hort J, Otto M, Hansson O, Parnetti L, Masters CL, Lleó A, Gonzalez-Escalante A, Contador J, Suarez-Calvet M, Fernández A, Puig-Pijoan A, Ortiz-Romero P, Jiménez-Moyano E, Minguillón C, Del Campo M, Teunissen C^*. Diagnostic performance of plasma A?42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study. Alzheimers Dement 2025; 21(6): e14573.
  Cites:1
  Cites:1
• Pilotto A^*, Quaresima V, Trasciatti C, Tolassi C, Bertoli D, Mordenti C, Galli A, Rizzardi A, Caratozzolo S, Zancanaro A, Contador J, Hansson O, Palmqvist S, De Santis G, Zetterberg H, Blennow K, Brugnoni D, Suarez-Calvet M, Ashton NJ, Padovani A. Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison. 2025; 148(2): 408-415.
  Cites:11
  Cites:11
• Gonzalez-Escalante A, Milà M, Brum WS, Ashton NJ, Ortiz-Romero P, Shekari M, Del Campo M, Anastasi F, Quijano-Rubio C, Kollmorgen G, Minguillón C, Sánchez-Benavides G, Grau-Rivera O, Gispert JD, Zetterberg H, Vilor-Tejedor N, Blennow K, Suarez-Calvet M^*. A plasma biomarker panel for detecting early amyloid-β accumulation and its changes in middle-aged cognitively unimpaired individuals at risk for Alzheimer's disease. EBioMedicine 2025; 116: 105741.
  Cites:0
  Cites:0
• Heo G, Xu Y, Wang E, Ali M, Oh HS, Moran-Losada P, Anastasi F, Gonzalez-Escalante A, Puerta R, Song S, Timsina J, Liu M, Western D, Gong K, Chen Y, Kohlfeld P, Flynn A, Thomas AG, Lowery J, Morris JC, Holtzman DM, Perlmutter JS, Schindler SE, Vilor-Tejedor N, Suarez-Calvet M, García-González P, Marquié M, Fernández MV, Boada M, Cano A, Ruiz-González A, Zhang B, Bennett DA, Benzinger T, Wyss-Coray T, Ibanez L, Sung YJ, Cruchaga C^*. Large-scale plasma proteomic profiling unveils diagnostic biomarkers and pathways for Alzheimer's disease. Nat Aging. 2025; 5(6): 1114-1131.
  Cites:4
  Cites:4
• Akinci M, Aguilar-Dominguez P, Palpatzis E, Shekari M, García-Prat M, Deulofeu C, Fauria K^*, Garcia-Aymerich J, Gispert JD, Suarez-Calvet M, Grau-Rivera O, Sánchez-Benavides G, Arenaza-Urquijo EM^*, ALFA study. Physical activity changes during midlife link to brain integrity and amyloid burden. Alzheimers Dement 2025; 21(5): e70007.
  Cites:0
  Cites:0
• Vila-Castelar C, Akinci M, Palpatzis E, Aguilar-Dominguez P, Operto G, Kollmorgen G, Quijano-Rubio C, Blennow K, Zetterberg H, Falcon C, Fauria K, Gispert JD, Grau-Rivera O, Suarez-Calvet M, Arenaza-Urquijo EM, ALFA study (...,Hernandez-Villamizar F, López D, LUGO F, Marne P, Menchon T, Minguillón C, Sánchez-Benavides G, Shekari M, Vilor N,...). Sex/gender effects of glial reactivity on preclinical Alzheimer's disease pathology. Mol Psychiatr 2025; 30(4): 1430-1439.
  Cites:3
  Cites:3
• Palpatzis E, Akinci M, García-Prat M, Blennow K, Zetterberg H, Quijano-Rubio C, Kollmorgen G, Wild N, Gispert JD, Suarez-Calvet M, Grau-Rivera O, Fauria K^*, Brugulat-Serrat A, Sánchez-Benavides G, Arenaza-Urquijo EM^*, ALFA study. Grief and Economic Stressors by Sex, Gender, and Education: Associations With Alzheimer Disease-Related Outcomes. Neurology 2025; 104(8): e213377.
  Cites:1
  Cites:1
• Cacciaglia R, Falcón C, Sánchez-Benavides G, Brugulat-Serrat A, Milà M, Suarez-Calvet M, Molinuevo JL, Fauria K, Minguillón C, Kollmorgen G, Quijano-Rubio C, Blennow K, Zetterberg H, Lorenzini L, Wink AM, Ingala S, Barkhof F, Ritchie CW, Gispert JD^*, ALFA study. Soluble Aβ pathology predicts neurodegeneration and cognitive decline independently on p-tau in the earliest Alzheimer's continuum: Evidence across two independent cohorts. Alzheimers Dement 2025; 21(2): e14415.
  Cites:0
  Cites:0
• Anastasi F, Fernández A, Ashton NJ, Ortiz-Romero P, Torres-Torronteras J, Gonzalez-Escalante A, Milà M, Contador J, García-Escobar G, Manero RM, Navalpotro I, Jiménez-Moyano E, Sahajan A, Hao Q, Zhang B, Jeromin A, Le Bastard N, Nadal A, Mousavi T, Kollmorgen G, Carboni M, Grau-Rivera O, Zetterberg H, Del Campo M, Blennow K, Puig-Pijoan A^*, Suarez-Calvet M^*. A head-to-head comparison of plasma biomarkers to detect Alzheimer's disease in a memory clinic. Alzheimers Dement 2025; 21(2): e14609.
  Cites:1
  Cites:1
• Biel D^*, Suarez-Calvet M, Dewenter A, Steward A, Roemer SN, Dehsarvi A, Zhu Z, Pescoller J, Frontzkowski L, Kreuzer A, Haass C, Schöll M, Brendel M, Franzmeier N. Female sex is linked to a stronger association between sTREM2 and CSF p-tau in Alzheimer's disease. EMBO Mol Med 2025; 17(2): 235-248.
  Cites:1
  Cites:1
• Cacciaglia R^*, Shekari M, SALVADÓ G, Milà M, Falcón C, Sánchez-Benavides G, Minguillón C, Fauria K, Grau-Rivera O, Molinuevo JL, Blennow K, Zetterberg H, Quevenco FC, Suarez-Calvet M, Gispert JD, ALFA Study. The CSF p-tau/β-amyloid 42 ratio correlates with brain structure and fibrillary β-amyloid deposition in cognitively unimpaired individuals at the earliest stages of pre-clinical Alzheimer's disease. Brain Commun . 2025; 7(1): fcae451 (Acceptat).
  Cites:1
  Cites:1